FAQ’s
Frequently asked questions about how Nordic Trial Partners works across Sweden, Norway and Denmark, and what an engagement involves.
-
Foremost Sweden, Norway and Denmark, with local presence in these countries. Covering all three Scandinavian markets through one point of contact is uncommon; many consultancies work in a single country. Sponsors and CROs get regional reach without coordinating several local providers.
Global work can be taken on remotely. -
Study start-up is the work that gets a trial site ready to start recruiting study participants. It covers site identification and feasibility assessment, ethics committee and competent authority applications, site contract negotiations as well as site setup and activation. Handled well, it shortens the gap between the sponsor deciding on conducting a study until the site has recruited the first study participant.
-
Yes. Both pharmaceutical and medical device studies are supported, including the different regulatory requirements each carries, such as EU MDR for devices and EU CTR for pharmaceuticals.
-
Yes. Nordic Trial Partners works as a subcontractor to international CROs that need local Nordic capacity, and directly as a consultant for biotechs and larger companies running studies in the region. We also take on assignments run under staffing companies.
-
In short, the limiting factors are usually on the client’s side.
Nordic Trial Partners keeps contracting and onboarding deliberately fast, with availability outside standard hours. The aim is to remove the delays that often sit between initial discussion of an assignment and starting the operational work.
From experience Nordic Trial Partners has a response turn-around-time under 12 hours and provides all necessary documentation expedited. Client contracts have been accepted with a handful of comments, max. Interview availability prioritized. -
All work is carried out under confidentiality agreements. Any case examples shown on this site are anonymised, with no client names or identifying study details disclosed.
-
Yes. We have thorough experience monitoring pharma and medical device studies in all three countries. We know the differences of the local regulations and monitoring practices.
We also fulfill the important Danish regulatory requirement that the monitor needs to have one of the Scandinavian languages as mother tongue.
-
First and foremost, sincere thanks for your interest in working with us. We would never take anyone’s interest for granted. Below is a short summary why we think you should choose to work with us. Of course you are welcome to send us a message and we can schedule an upfront phone conversation where you could receive further details. We look forward to your message!
Every team member works directly with clients. There are no layers of middle management, no internal reporting structures that slow things down, and no pressure to bill hours over delivering quality. We move fast, communicate openly and take ownership of our work.
We are not just any company. 1 % of our annual gross sales is always provided to a widely renowned charity organization, with the aim to support children in need globally. This is a commitment we take very seriously.
Still have a question?
Get in touch to discuss your project. Typically responds within 24 hours.